TITLE

U.K. HOSPITAL TREATS CANCER PATIENTS WITH SMARTBEAM IMRT

PUB. DATE
September 2001
SOURCE
Worldwide Biotech;Sep2001, Vol. 13 Issue 9, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
5105330

 

Related Articles

  • Playing it safe around cesium implants. Siebel, Jenifer // RN;Oct83, Vol. 46 Issue 10, p42 

    Provides guidelines in reducing the risk in radioactive cesium therapy used in cancer treatment. Procedure used in cesium therapy; Precautions before and after the insertion of the cesium.

  • Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy. Zalutsky, Michael R.; Vaidyanathan, Ganesan // Current Pharmaceutical Design;Sep2000, Vol. 6 Issue 14, p1433 

    Targeted radiotherapy or endoradiotherapy is an appealing approach to cancer treatment because of the potential for delivering curative doses of radiation to tumor while sparing normal tissues. Radionuclides that decay by the emission of a-particles such as the heavy halogen astatine-211 ( 211...

  • Intraoperative radiation: Taking a clear shot at cancer. Young, Cynthia M. // RN;Aug87, Vol. 50 Issue 8, p41 

    Focuses on the use of intraoperative radiation in the treatment of cancer. Description of the process involved in intraoperative radiation therapy; Procedures employed in the treatment; Complications related to intraoperative radiation therapy.

  • Long-term androgen suppression superior to short-term in locally advanced prostate cancer.  // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p26 

    This article focuses on a study which examined the efficacy of long-term or short-term radiotherapy plus androgen suppression in treating locally advanced prostate cancer.

  • Comment: Less toxicity a worthy goal, but will centers adapt? Moul, Judd W. // Urology Times;Sep2002, Vol. 30 Issue 9, p12 

    Comments on the recommendation made by an international consensus committee on the use of three-dimensional, high-dose conformal radiation therapy to treat patients with clinical stage T2 prostate cancer. Patient benefits; Expectations that U.S.-based clinical practice might not be receptive to...

  • Model predicts demand for PCa radiotherapy services. Tennant, Scott // Urology Times;Mar2003, Vol. 31 Issue 3, p18 

    Details an evidence-based approach to estimating demand for radiation treatment among prostate cancer patients. Indications for radiotherapy in prostate cancer; Determining the incidence of each indication in a typical North American prostate cancer population.

  • Fears over radiotherapy fractionation regimens in breast cancer. Roger, Alan // BMJ: British Medical Journal (International Edition);07/18/98, Vol. 317 Issue 7152, p155 

    Editorial. Discusses radiotherapy fractionation in breast cancer in Great Britain. Benefits of radiation treatment fractionation (RTF); Definition of RTF; Reference to radiotherapy during the 1930s; Details on the variation and pressures of radiotherapy practices for breast cancer.

  • Oncology. Tattersall, Martin H N; Thomas, Hilary // BMJ: British Medical Journal (International Edition);02/13/99, Vol. 318 Issue 7181, p445 

    Presents information on a study which discussed several advances in oncology. Treatment advances in areas other than radiation therapy and cytotoxic chemotherapy; Methodology; Supportive care needs of cancer patients; Clinical trials; Conclusions.

  • Erratum: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.  // Radiation Oncology;2015, Vol. 10 Issue 1, p1 

    A correction to the article on the oligometastases in prostate cancer and on radiotherapy options is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics